Aspirin Therapy Mortality Reduction Confirmation Urged In BMJ Editorial
This article was originally published in The Tan Sheet
Executive Summary
A "definitively positive trial" on aspirin's effectiveness at lowering mortality due to coronary heart disease is still needed, John Cleland, University of Hull, UK, states in an editorial in the Jan. 12 British Medical Journal
You may also be interested in...
Bayer “ASAP” Campaign Includes Aspirin Donations, Focus On Women
Bayer will contribute three million aspirin tablets to hospitals and clinics in five communities nationwide as part of its "Saving Lives ASAP" campaign, which launched in Washington, D.C. Feb. 12
Bayer “ASAP” Campaign Includes Aspirin Donations, Focus On Women
Bayer will contribute three million aspirin tablets to hospitals and clinics in five communities nationwide as part of its "Saving Lives ASAP" campaign, which launched in Washington, D.C. Feb. 12
Bayer “ASAP” Campaign Includes Aspirin Donations, Focus On Women
Bayer will contribute three million aspirin tablets to hospitals and clinics in five communities nationwide as part of its "Saving Lives ASAP" campaign, which launched in Washington, D.C. Feb. 12